Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India

Mycopathologia

Volumn 161, Issue 3, 2006, Pages 153-159

  Girish Kumar, C P ^a   Hanafy, Ahmed Medhat ^b   Katsu, Masakazu ^b   Mikami, Yuzuru ^b   Menon, Thangam ^a  

^a UNIVERSITY OF MADRAS   (India)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Antifungal susceptibility; Candida albicans; Genotype; Resistance; Serotype

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA; RIBOSOME RNA; RNA, RIBOSOMAL, 25S;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHEMISTRY; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SEROTYPING;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DNA, FUNGAL; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; INDIA; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL; SEROTYPING; VARIATION (GENETICS);

CANDIDA ALBICANS;

EID: 32944457191     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-005-9210-6     Document Type: Article

References (33)

1. J Wingrad W Merz R Saral 1979 Candida tropicalis: A major pathogen in immunocompromised patients Ann Intern Med 91 529 543
2. JR Wingrad 1995 Importance of Candida species other than C. albicans as pathogens in oncology patients Clin Infect Dis 20 115 125
3. DC Coleman MG Rinaldi KA Haynes JH Rex RC Summerbell EJ Anaissie A Li DJ Sullivan 1998 Importance of Candida species other than Candida albicans as opportunistic pathogens Med Mycol 36 156 165
4. EM Johnson DW Warnock J Luker SR Porter C Scully 1995 Emergence of azole drug resistance in Candida species from HIV infected patients receiving prolonged fluconazole therapy for oral candidosis J Antimicrob Chemother 35 103 114
5. JH Rex MG Rinaldi MA Pfaller 1995 Resistance of Candida species to fluconazole Antimicrob Agents Chemother 39 1 8
6. M Nucci AL Colombo 2002 Emergence of resistant Candida in neutropenic patients Braz J Infect Dis 6 124 128
7. M Hong-Nguyen CY Yu 1998 Voriconazole against fluconazole- susceptible and resistant Candida isolates: In vitro efficacy compared with that of itraconazole and ketoconazole J Antimicrob Chemother 42 253 256
8. KV Clemons F Feroze K Holmberg DA Stevens 1997 Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods J Clin Microbiol 35 1332 1336
9. A Espinel-Ingroff JA Vazquez D Boikov MA Pfaller 1999 Evaluation of DNA-based typing procedures for strain categorization of Candida spp Diag Microbiol Infect Dis 33 231 239
10. MJ [tmp] McCullough KV Clemons DA Stevens 1999 Molecular epidemiology of the global and temporal diversity of Candida albicans Clin Infect Dis 29 1220 1225
11. JL Lopez-Ribot R Kaufman-McAtee WR Kirkpatrick S Perea T Frost-Patterson 2000 Comparison of DNA-based typing methods to assess genetic diversity and strain relatedness among Candida albicans clinical isolates Rev Iberoam Micol 17 49 54
12. MJ Mc Cullough KV Clemons JH Mc Cusker DA Stevens 1998 Intergenic transcribed spacer PCR ribotyping for differentiation of Saccharomyces species and interspecific hybrids J Clin Microbiol 36 1035 1038
13. MJ [tmp] McCullough KV Clemons DA Stevens 1999 Molecular and phenotypic characterization of genotype C. albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea J Clin Microbiol 37 417 421
14. DJ Sullivan G Moran S Donnelly S Gee E Pinjon B [tmp] McCartan DB Shanley DC Coleman 1999 Candida dubliniensis: An update Rev Iberoamer Micol 16 72 76
15. HC Gugnani K Becker W Fegeler S Basu D Chattopadhya U Baveja S Satyanarayan T Kalghatgi A Murlidhar 2003 Oropharyngeal carriage of Candida species in HIV-infected patients in India Mycoses 46 281 288
16. M Tamura K Watnabe Y Mikami K Yazawa K Nishimura 2001 Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: Analysis reveals a new genotype of C. albicans with group I intron J Clin Microbiol 39 4309 4315
17. BC Millar JE Moore J Xu MJ Walker S Hedderwick R [tmp] McMullan 2002 Genotypic subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis Lett Appl Microbiol 35 102 106
18. ZC Karahan H Guriz H Agirbasi N Balaban JS Gocmen D Aysev N Akar 2004 Genotype distribution of Candida albicans by 25S intron analysis with regard to invasiveness Mycoses 47 465 469
19. NCCLS 1997 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27A National Committee for Clinical Laboratory Standards Wayne, PA
20. G Kovacicova Y Krupova M Lovaszova A Roidova J Trupl A Liskova J Hanzen P Milosovic M Lamosova L Macekova Z Szovenyiova A Purgelova T Obertik J Bille V Krcmery 2000 Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: Is there a correlation between in vitro resistance to fluconazole and the outcome of fungemia? J Infect Chemother 6 216 221
21. MF Cheng KW Yu RB Tang YH Fan YL Yang KS Hsieh M Ho HJ Lo 2004 Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999 Diagn Microbiol Infect Dis 48 33 37
22. A Espinel-Ingroff F Barchiesi M Cuenca-Estrella MA Pfaller M Rinaldi JL Rodriguez-Tudela PE Verweij 2005 International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole J Clin Microbiol 43 3884 3889
23. A Espinel-Ingroff F Barchiesi M Cuenca-Estrella A Fothergill MA Pfaller M Rinaldi JL Rodriguez-Tudela PE Verweij 2005 Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: A collaborative study J Clin Microbiol 43 4535 4540
24. BA Arthington-Skaggs W Lee-Yang MA Ciblak JP Frade ME Brandt RA Hajjeh LH Harrison AN Sofair DW Warnock 2002 Candidemia Active Surveillance Group Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates Antimicrob Agents Chemother 46 2477 2481
25. SG Revankar WR Kirkpatrick RK [tmp] McAtee OP Dib AW Fothergill SW Redding MG Rinaldi SG Hilsenbeck TF Patterson 1998 A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: Clinical outcomes and development of fluconazole resistance Am J Med 105 1 7 11
26. J Xu AR Ramos R Vilgalys TG Mitchell 2000 Clonal and spontaneous origins of fluconazole resistance in Candida albicans J Clin Microbiol 38 3 1214 1220
27. F Barchiesi RJ Hollis M Del Poeta DA [tmp] McGough G Scalise MG Rinaldi MA Pfaller 1995 Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis Clin Infect Dis 21 3 561 564
28. FM Muller M Kasai A Francesconi B Brillante M Roden J Peter SJ Chanock TJ Walsh 1999 Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis J Clin Microbiol 37 10 3405 3408
29. D Sanglard FC Odds 2002 Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences Lancet Infect Dis 2 73 85
30. V Vidotto CY Koga-Ito R Milano B Fianchino J Ponton 1999 Correlation between germ tube production, phospholipase activity and serotype distribution in Candida albicans Rev Iberoam Micol 16 208 210
31. DL Brawner JE Cutler 1989 Oral Candida albicans isolates from non-hospitalised normal carriers, immunocompetent hospitalsed patients and immunocompromised patients with or without acquired immunodeficiency syndrome J Clin Microbiol 27 1335 1341
32. A Velegraki 1995 In vitro susceptibility to itraconazole and fluconazole of switch phenotypes of Candida albicans serotypes A and B, isolated from immunocompromised hosts J Med Vet Mycol 33 83 85
33. S Mercure S Montplaisir G Lemay 1993 Correlation between the presence of a self-splicing intron in the 25SrDNA of C. albicans and strain susceptibility to 5-flucytosine Nucleic Acids Res 21 6020 6027